These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 29022765

  • 1. Polymorphisms in genes involved in vasoactive eicosanoid synthesis affect cardiovascular risk in renal transplant recipients.
    Gervasini G, Luna E, Garcia-Pino G, Azevedo L, Mota-Zamorano S, José Cubero J.
    Curr Med Res Opin; 2018 Feb; 34(2):247-253. PubMed ID: 29022765
    [Abstract] [Full Text] [Related]

  • 2. Polymorphisms in CYP-mediated arachidonic acid routes affect the outcome of renal transplantation.
    Gervasini G, García-Cerrada M, Vergara E, García-Pino G, Alvarado R, Fernández-Cavada MJ, Barroso S, Doblaré E, Cubero JJ.
    Eur J Clin Invest; 2015 Oct; 45(10):1060-8. PubMed ID: 26214067
    [Abstract] [Full Text] [Related]

  • 3. Polymorphisms in vasoactive eicosanoid genes of kidney donors affect biopsy scores and clinical outcomes in renal transplantation.
    Mota-Zamorano S, González LM, Luna E, Fernández JJ, Gómez Á, Nieto-Fernández A, Robles NR, Gervasini G.
    PLoS One; 2019 Oct; 14(10):e0224129. PubMed ID: 31622444
    [Abstract] [Full Text] [Related]

  • 4. Influence of ABCC2, CYP2C8, and CYP2J2 Polymorphisms on Tacrolimus and Mycophenolate Sodium-Based Treatment in Brazilian Kidney Transplant Recipients.
    Genvigir FDV, Nishikawa AM, Felipe CR, Tedesco-Silva H, Oliveira N, Salazar ABC, Medina-Pestana JO, Doi SQ, Hirata MH, Hirata RDC.
    Pharmacotherapy; 2017 May; 37(5):535-545. PubMed ID: 28316087
    [Abstract] [Full Text] [Related]

  • 5. Risk factors for post-transplant diabetes mellitus in renal transplant: Role of genetic variability in the CYP450-mediated arachidonic acid metabolism.
    Gervasini G, Luna E, García-Cerrada M, García-Pino G, Cubero JJ.
    Mol Cell Endocrinol; 2016 Jan 05; 419():158-64. PubMed ID: 26483195
    [Abstract] [Full Text] [Related]

  • 6. Association of CYP2C8, CYP2C9 and CYP2J2 gene polymorphisms with myocardial infarction in South Indian population.
    Arun Kumar AS, Kumar SS, Umamaheswaran G, Kesavan R, Balachandar J, Adithan C.
    Pharmacol Rep; 2015 Feb 05; 67(1):97-101. PubMed ID: 25560582
    [Abstract] [Full Text] [Related]

  • 7. Single nucleotide polymorphisms in the CYP2J2 and CYP2C8 genes and the risk of hypertension.
    King LM, Gainer JV, David GL, Dai D, Goldstein JA, Brown NJ, Zeldin DC.
    Pharmacogenet Genomics; 2005 Jan 05; 15(1):7-13. PubMed ID: 15864120
    [Abstract] [Full Text] [Related]

  • 8. Sex- and isoform-specific mechanism of neuroprotection by transgenic expression of P450 epoxygenase in vascular endothelium.
    Jia J, Davis CM, Zhang W, Edin ML, Jouihan S, Jia T, Bradbury JA, Graves JP, DeGraff LM, Lee CR, Ronnekleiv O, Wang R, Xu Y, Zeldin DC, Alkayed NJ.
    Exp Neurol; 2016 May 05; 279():75-85. PubMed ID: 26902473
    [Abstract] [Full Text] [Related]

  • 9. CYP2J2 and CYP2C8 polymorphisms and coronary heart disease risk: the Atherosclerosis Risk in Communities (ARIC) study.
    Lee CR, North KE, Bray MS, Couper DJ, Heiss G, Zeldin DC.
    Pharmacogenet Genomics; 2007 May 05; 17(5):349-58. PubMed ID: 17429317
    [Abstract] [Full Text] [Related]

  • 10. CYP2C8 and CYP2J2 gene variations increase the risk of hypertensive intracerebral hemorrhage.
    Li Y, You C, Liu Z, He F, Zhao F, Song X, Xie Z, Wei S, Yang Y, Wei H, Che F, Yu J.
    J Stroke Cerebrovasc Dis; 2023 Mar 05; 32(3):106974. PubMed ID: 36587509
    [Abstract] [Full Text] [Related]

  • 11. Genetic markers in the EET metabolic pathway are associated with outcomes in patients with aneurysmal subarachnoid hemorrhage.
    Donnelly MK, Conley YP, Crago EA, Ren D, Sherwood PR, Balzer JR, Poloyac SM.
    J Cereb Blood Flow Metab; 2015 Feb 05; 35(2):267-76. PubMed ID: 25388680
    [Abstract] [Full Text] [Related]

  • 12. Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2.
    Spiecker M, Darius H, Hankeln T, Soufi M, Sattler AM, Schaefer JR, Node K, Börgel J, Mügge A, Lindpaintner K, Huesing A, Maisch B, Zeldin DC, Liao JK.
    Circulation; 2004 Oct 12; 110(15):2132-6. PubMed ID: 15466638
    [Abstract] [Full Text] [Related]

  • 13. The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases.
    Xu X, Zhang XA, Wang DW.
    Adv Drug Deliv Rev; 2011 Jul 18; 63(8):597-609. PubMed ID: 21477627
    [Abstract] [Full Text] [Related]

  • 14. Eicosanoids via CYP450 and cardiovascular disease: Hints from genetic and nutrition studies.
    Fava C, Bonafini S.
    Prostaglandins Other Lipid Mediat; 2018 Nov 18; 139():41-47. PubMed ID: 30296490
    [Abstract] [Full Text] [Related]

  • 15. Role of cytochrome P450 2C8 and 2J2 genotypes in calcineurin inhibitor-induced chronic kidney disease.
    Smith HE, Jones JP, Kalhorn TF, Farin FM, Stapleton PL, Davis CL, Perkins JD, Blough DK, Hebert MF, Thummel KE, Totah RA.
    Pharmacogenet Genomics; 2008 Nov 18; 18(11):943-53. PubMed ID: 18769365
    [Abstract] [Full Text] [Related]

  • 16. Time-dependent expression pattern of cytochrome P450 epoxygenases and soluble epoxide hydrolase in normal human placenta.
    Cizkova K, Tauber Z.
    Acta Histochem; 2018 Aug 18; 120(6):513-519. PubMed ID: 29908721
    [Abstract] [Full Text] [Related]

  • 17. Polymorphisms of CYP2C8, CYP2C9 and CYP2C19 and risk of coronary heart disease in Russian population.
    Polonikov A, Kharchenko A, Bykanova M, Sirotina S, Ponomarenko I, Bocharova A, Vagaytseva K, Stepanov V, Bushueva O, Churnosov M, Solodilova M.
    Gene; 2017 Sep 05; 627():451-459. PubMed ID: 28687336
    [Abstract] [Full Text] [Related]

  • 18. Human cytochrome P450 epoxygenases: variability in expression and role in inflammation-related disorders.
    Shahabi P, Siest G, Meyer UA, Visvikis-Siest S.
    Pharmacol Ther; 2014 Nov 05; 144(2):134-61. PubMed ID: 24882266
    [Abstract] [Full Text] [Related]

  • 19. Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study.
    Svensson M, Dahle DO, Mjøen G, Weihrauch G, Scharnagl H, Dobnig H, März W, Jardine A, Fellström B, Holdaas H.
    Nephrol Dial Transplant; 2012 Jun 05; 27(6):2571-5. PubMed ID: 22172725
    [Abstract] [Full Text] [Related]

  • 20. CYP Genetic Variants, CYP Metabolite Levels, and Neurologic Deterioration in Acute Ischemic Stroke in Chinese Population.
    Yi X, Lin J, Wang C, Zhou Q.
    J Stroke Cerebrovasc Dis; 2017 May 05; 26(5):969-978. PubMed ID: 27916259
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.